U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acute myeloid leukemia with CEBPA somatic mutations

MedGen UID:
1640289
•Concept ID:
C4707178
•
Neoplastic Process
Synonym: Acute myeloid leukemia with mutated CEBPA
SNOMED CT: Acute myeloid leukemia with CEBPA somatic mutations (764855007); Acute myeloid leukemia with CCAAT/enhancer binding protein alpha somatic mutation (764855007)
 
Monarch Initiative: MONDO:0017894
Orphanet: ORPHA319480

Definition

A subtype of acute myeloid leukaemia with recurrent genetic abnormalities, characterised by clonal proliferation of myeloid blasts harbouring somatic mutations of the CEBPA gene in the bone marrow, blood and rarely other tissues. It can present with anaemia, thrombocytopenia, and other nonspecific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). [from SNOMEDCT_US]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcute myeloid leukemia with CEBPA somatic mutations

Professional guidelines

PubMed

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AK
Blood Adv 2022 Oct 11;6(19):5570-5581. doi: 10.1182/bloodadvances.2022007544. PMID: 35788257Free PMC Article
Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.
Walker AR, Marcucci G
J Natl Compr Canc Netw 2014 Apr;12(4):527-34. doi: 10.6004/jnccn.2014.0057. PMID: 24717571

Recent clinical studies

Etiology

The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P, Brown S, Williams M, White T, Xie W, Cui W, Peker D, Lei L, Kunder CA, Wang HY, Murray SS, Vagher J, Kovacsovics T, Patel JL
Blood 2022 Aug 18;140(7):716-755. doi: 10.1182/blood.2021015135. PMID: 35671390Free PMC Article
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL, Hahn CN, Scott HS
Blood 2020 Jul 2;136(1):24-35. doi: 10.1182/blood.2019000937. PMID: 32430494Free PMC Article
Molecular therapy for acute myeloid leukaemia.
Coombs CC, Tallman MS, Levine RL
Nat Rev Clin Oncol 2016 May;13(5):305-18. Epub 2015 Dec 1 doi: 10.1038/nrclinonc.2015.210. PMID: 26620272Free PMC Article
Adult acute leukemia.
Cornell RF, Palmer J
Dis Mon 2012 Apr;58(4):219-38. doi: 10.1016/j.disamonth.2012.01.011. PMID: 22449370
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL
N Engl J Med 2012 Mar 22;366(12):1079-89. Epub 2012 Mar 14 doi: 10.1056/NEJMoa1112304. PMID: 22417203Free PMC Article

Diagnosis

The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P, Brown S, Williams M, White T, Xie W, Cui W, Peker D, Lei L, Kunder CA, Wang HY, Murray SS, Vagher J, Kovacsovics T, Patel JL
Blood 2022 Aug 18;140(7):716-755. doi: 10.1182/blood.2021015135. PMID: 35671390Free PMC Article
Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
Mendoza H, Podoltsev NA, Siddon AJ
Int J Lab Hematol 2021 Jul;43 Suppl 1:86-95. doi: 10.1111/ijlh.13517. PMID: 34288448
Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Lu J, Chen M, Hua H, Qin W, Zhang R, Lu X, Chao H
Int J Lab Hematol 2021 Dec;43(6):1483-1490. Epub 2021 Jul 16 doi: 10.1111/ijlh.13648. PMID: 34270876
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL, Hahn CN, Scott HS
Blood 2020 Jul 2;136(1):24-35. doi: 10.1182/blood.2019000937. PMID: 32430494Free PMC Article
Adult acute leukemia.
Cornell RF, Palmer J
Dis Mon 2012 Apr;58(4):219-38. doi: 10.1016/j.disamonth.2012.01.011. PMID: 22449370

Therapy

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AK
Blood Adv 2022 Oct 11;6(19):5570-5581. doi: 10.1182/bloodadvances.2022007544. PMID: 35788257Free PMC Article
Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
Zhu H, Yang B, Liu J, Wu W, Ling Y
Medicine (Baltimore) 2020 Jan;99(3):e18888. doi: 10.1097/MD.0000000000018888. PMID: 32011516Free PMC Article
Translational implications of somatic genomics in acute myeloid leukaemia.
Meyer SC, Levine RL
Lancet Oncol 2014 Aug;15(9):e382-94. doi: 10.1016/S1470-2045(14)70008-7. PMID: 25079101
Adult acute leukemia.
Cornell RF, Palmer J
Dis Mon 2012 Apr;58(4):219-38. doi: 10.1016/j.disamonth.2012.01.011. PMID: 22449370
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL
N Engl J Med 2012 Mar 22;366(12):1079-89. Epub 2012 Mar 14 doi: 10.1056/NEJMoa1112304. PMID: 22417203Free PMC Article

Prognosis

Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Lu J, Chen M, Hua H, Qin W, Zhang R, Lu X, Chao H
Int J Lab Hematol 2021 Dec;43(6):1483-1490. Epub 2021 Jul 16 doi: 10.1111/ijlh.13648. PMID: 34270876
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL, Hahn CN, Scott HS
Blood 2020 Jul 2;136(1):24-35. doi: 10.1182/blood.2019000937. PMID: 32430494Free PMC Article
Molecular therapy for acute myeloid leukaemia.
Coombs CC, Tallman MS, Levine RL
Nat Rev Clin Oncol 2016 May;13(5):305-18. Epub 2015 Dec 1 doi: 10.1038/nrclinonc.2015.210. PMID: 26620272Free PMC Article
Adult acute leukemia.
Cornell RF, Palmer J
Dis Mon 2012 Apr;58(4):219-38. doi: 10.1016/j.disamonth.2012.01.011. PMID: 22449370
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL
N Engl J Med 2012 Mar 22;366(12):1079-89. Epub 2012 Mar 14 doi: 10.1056/NEJMoa1112304. PMID: 22417203Free PMC Article

Clinical prediction guides

Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J, Song H, Kim SM, Kim S, Kwon SR, Lee YE, Jeong D, Park JH, Kwon S, Yun H, Lee DS
Hum Genomics 2023 Feb 23;17(1):13. doi: 10.1186/s40246-023-00458-8. PMID: 36814285Free PMC Article
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation.
Redondo Monte E, Leubolt G, Windisch R, Kerbs P, Dutta S, Landspersky T, Istvánffy R, Oostendorp RAJ, Chen-Wichmann L, Herold T, Cusan M, Schotta G, Wichmann C, Greif PA
Exp Hematol 2022 Apr;108:26-35. Epub 2022 Feb 16 doi: 10.1016/j.exphem.2022.02.002. PMID: 35181392
Germline DNMT3A mutation in familial acute myeloid leukaemia.
DiNardo CD, Beird HC, Estecio M, Hardikar S, Takahashi K, Bannon SA, Borthakur G, Jabbour E, Gumbs C, Khoury JD, Routbort M, Gong T, Kondo K, Kantarjian H, Garcia-Manero G, Chen T, Futreal PA
Epigenetics 2021 May;16(5):567-576. Epub 2020 Aug 28 doi: 10.1080/15592294.2020.1809871. PMID: 32856987Free PMC Article
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL, Hahn CN, Scott HS
Blood 2020 Jul 2;136(1):24-35. doi: 10.1182/blood.2019000937. PMID: 32430494Free PMC Article
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL
N Engl J Med 2012 Mar 22;366(12):1079-89. Epub 2012 Mar 14 doi: 10.1056/NEJMoa1112304. PMID: 22417203Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Reviews

    Related information

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...